Subject
Pharmacology,Molecular Medicine,Physiology
Reference15 articles.
1. Intensive glucose control and macrovascular outcomes in type 2 diabetes;Control Group;Diabetologia,2009
2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials;Sattar;Lancet Diabetes Endocrinol.,2021
3. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a Meta-analysis;McGuire;JAMA Cardiol.,2021
4. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD);Davies;Diabetologia.,2022
5. Efficacy and safety over 2 years of Exenatide plus Dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3;Jabbour;Randomized Controlled Trial. Diabetes Care.,2020